CN108289877A - 美西替康的药物组合物 - Google Patents

美西替康的药物组合物 Download PDF

Info

Publication number
CN108289877A
CN108289877A CN201680071229.1A CN201680071229A CN108289877A CN 108289877 A CN108289877 A CN 108289877A CN 201680071229 A CN201680071229 A CN 201680071229A CN 108289877 A CN108289877 A CN 108289877A
Authority
CN
China
Prior art keywords
phosphatide
west
health
egg
sucrose
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201680071229.1A
Other languages
English (en)
Chinese (zh)
Inventor
张喜全
董平
张焕青
程艳菊
周浩
蒋波
刘飞
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Chia Tai Tianqing Pharmaceutical Group Co Ltd
Original Assignee
Chia Tai Tianqing Pharmaceutical Group Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chia Tai Tianqing Pharmaceutical Group Co Ltd filed Critical Chia Tai Tianqing Pharmaceutical Group Co Ltd
Publication of CN108289877A publication Critical patent/CN108289877A/zh
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/337—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Dispersion Chemistry (AREA)
  • Medicinal Preparation (AREA)
CN201680071229.1A 2015-12-08 2016-12-07 美西替康的药物组合物 Pending CN108289877A (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CN201510896290 2015-12-08
CN2015108962907 2015-12-08
PCT/CN2016/108841 WO2017097197A1 (fr) 2015-12-08 2016-12-07 Composition pharmaceutique de moexitecan

Publications (1)

Publication Number Publication Date
CN108289877A true CN108289877A (zh) 2018-07-17

Family

ID=59012690

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201680071229.1A Pending CN108289877A (zh) 2015-12-08 2016-12-07 美西替康的药物组合物

Country Status (2)

Country Link
CN (1) CN108289877A (fr)
WO (1) WO2017097197A1 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN116803393B (zh) * 2023-08-24 2023-11-21 成都金瑞基业生物科技有限公司 一种pan-HER抑制剂的药物组合物及其制备方法

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004071466A2 (fr) * 2003-02-11 2004-08-26 Neopharm, Inc. Procede de production de preparations liposomales
CN101244039A (zh) * 2008-03-20 2008-08-20 江苏先声药物研究有限公司 一种制备难溶性药物脂质体制剂的新方法
CN101283983A (zh) * 2007-10-26 2008-10-15 南京长澳医药科技有限公司 一种稳定的喜树碱类药物脂质体组合物
CN101874788A (zh) * 2010-05-31 2010-11-03 沈阳药科大学 一种7-乙基-10-羟基喜树碱脂质体冻干粉针及其制备方法
CN102516258A (zh) * 2011-11-11 2012-06-27 南京美西宁医药科技有限责任公司 水溶性维生素e衍生物修饰的脂溶性抗癌药物化合物和制剂、该化合物的制备方法及应用

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004071466A2 (fr) * 2003-02-11 2004-08-26 Neopharm, Inc. Procede de production de preparations liposomales
CN101283983A (zh) * 2007-10-26 2008-10-15 南京长澳医药科技有限公司 一种稳定的喜树碱类药物脂质体组合物
CN101244039A (zh) * 2008-03-20 2008-08-20 江苏先声药物研究有限公司 一种制备难溶性药物脂质体制剂的新方法
CN101874788A (zh) * 2010-05-31 2010-11-03 沈阳药科大学 一种7-乙基-10-羟基喜树碱脂质体冻干粉针及其制备方法
CN102516258A (zh) * 2011-11-11 2012-06-27 南京美西宁医药科技有限责任公司 水溶性维生素e衍生物修饰的脂溶性抗癌药物化合物和制剂、该化合物的制备方法及应用

Also Published As

Publication number Publication date
WO2017097197A1 (fr) 2017-06-15

Similar Documents

Publication Publication Date Title
US11858958B2 (en) Blank liposome with ginsenoside Rg3 or its analog as membrane materials and preparations and uses thereof
CN102170866B (zh) 亲脂性或两亲性治疗剂在纳米乳剂中的包囊
CN108289846A (zh) 脂质体的制备方法
CA1333993C (fr) Structures porteuses de medicaments
CN103110579B (zh) 前列地尔注射剂
CN101524329B (zh) 双环醇亚微乳及其制备方法
CN104997759B (zh) 一种注射用总蟾毒内酯固体脂质纳米粒给药系统及其制备方法
CN108289877A (zh) 美西替康的药物组合物
CN101099733A (zh) 注射用紫杉醇冻干乳剂及其制备方法
CN105055315A (zh) 一种交联线粒体靶向阿霉素脂质体及其制备方法
CA2333162C (fr) Procede de production d'une preparation composite contenant de l'acide nucleique
KR20140023669A (ko) 무복계면 스핑고리피드
CN106580945B (zh) 一种考布他汀a4衍生物及其制剂
Jain et al. Novel self-micro emulsifying drug delivery system for safe intramuscular delivery with improved pharmacodynamics and pharmacokinetics
CN102247320B (zh) 一种依托泊苷长循环乳剂及其制备方法
CN105944120B (zh) 一种载有十二硼烷马来酰亚胺丙酰哌嗪七甲川菁硫醚盐的叶酸脂质体及其制备方法和应用
CN106389333B (zh) 由肿瘤微环境控制粒径大小及药物释放的多组分脂质复合系统、其制备方法与应用
CN101829053B (zh) 一种醋酸棉酚静脉注射脂肪乳剂的制备方法
CN109172520A (zh) 一种紫杉烷类衍生物tm-2胶束注射液及其制备方法与应用
CN102178651B (zh) 一种维a酸脂肪乳注射液及其制备方法
CN1743337B (zh) 一种紫杉醇衍生物及其药物组合物
KR20140043580A (ko) 무복계면 진세노사이드 및 그 제조방법
Vettorato et al. Deformable Vesicles with Edge Activators for the Transdermal Delivery of Non-Psychoactive Cannabinoids
KR20140043574A (ko) 무복계면 코엔자임 큐텐 및 그 제조방법
CN117257917A (zh) Mastoparan M肽脂质体制剂及其制备方法和用途

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication
RJ01 Rejection of invention patent application after publication

Application publication date: 20180717